Regal Rexnord (NYSE:RRX) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings, Stock Drops

Regal Rexnord (NYSE:RRX) reported Q2 CY2026 revenue of $1.56 billion, up 4.2% year on year but below Wall Street estimates. Adjusted non-GAAP EPS was $2.99, up from $2.48 and above consensus. The article also cites operating margin of 13.8% and expects revenue growth of 9.4% and EPS to rise to $12.08 over 12 months. Shares fell 8.1% to $202.26.

Original reporting
Published Aug 5, 2026, 12:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 12:50 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Regal Rexnord (NYSE:RRX) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings, Stock Drops — source image
Decision brief

The 30-second read

$RRXNeutralMed
01

Why it matters

For traders, the key tension is top-line underperformance versus profitability strength. The immediate -8.1% move indicates the market weighted the revenue miss more heavily than the EPS beat.

02

Market read

RRX’s earnings mix (EPS and margins up, revenue and organic revenue slightly down) is likely to drive near-term positioning around guidance credibility and demand visibility.

03

What to watch

Share count dilution (63.2% over five years) can mask underlying per-share performance; traders may want to separate operating leverage from per-share dilution effects.

Relevance 8/10Novelty 6/10Timing: post-Q2 results, immediately after the earnings release

Background

The article frames RRX’s Q2 CY2026 results versus analyst expectations, highlighting a revenue shortfall alongside an adjusted EPS beat and higher operating margin.

Company-level read

Ticker impact

$RRXNeutralMedium confidence
Context

Regal Rexnord reported Q2 CY2026 revenue of $1.56B, up 4.2% YoY but below Wall Street estimates, while adjusted EPS was $2.99.

Expected impact

Near-term downside bias likely persists until revenue/organic growth re-accelerates, despite EPS and margin support.

Evidence & confidence

The article provides a concrete earnings print (revenue miss, EPS beat) plus the immediate stock reaction (-8.1%), which typically keeps traders focused on top-line trajectory and organic demand.

Market effects

Signals ongoing cyclicality in industrials demand, with investors rewarding margin discipline but penalizing organic/top-line softness.

No specific regional spillover mentioned.

No explicit global macro or international event linkage beyond organic revenue being dampened by FX/divestitures.

Counterpoint

The revenue miss may be less fundamental if organic revenue was only slightly short and margins expanded, suggesting earnings quality could remain resilient.

Key entities

  • Regal Rexnord

    Industrials products and automation company reporting Q2 CY2026 results, including revenue miss and adjusted EPS beat.

Related articles

$AMBAMedAI 8/10

Usain Bolt Just Got an AI Rival – Meet the Stocks Behind It

Unitree Robotics, a Chinese company, unveiled a humanoid robot 'Superman' claiming it runs faster than Usain Bolt. The company's IPO on the Shanghai Stock Exchange saw shares surge 460%, valuing it at $50 billion. Investors are betting on the humanoid robotics sector and its supply chain, including companies like Ambarella, Ouster, Cognex, Regal Rexnord, and Harmonic Drive Systems, which saw gains in July.

$RRXMedAI 8/10

Regal Rexnord (RRX) Q2 2026 Earnings Call Transcript

Regal Rexnord (RRX) Q2 2026 earnings call reported orders up 8.8% year over year, or 8.1% excluding data center, and sales up 4.2% (3.3% organic). Adjusted gross margin was 39.8% (37.8% excluding IEEPA refunds of $32 million). Adjusted EPS was $2.99, and adjusted free cash flow was $154 million.

$RRXMed

Regal Rexnord Q2 Earnings Call Highlights

Regal Rexnord (NYSE:RRX) reported Q2 adjusted EPS of $2.99 ($2.60 excluding $32m tariff refunds) and adjusted EBITDA margin of 23.5% (21.5% ex-refunds). Automation & Motion Control (AMC) delivered 15.6% organic sales growth, orders up 17.1% and book-to-bill 1.02. Full-year guidance: sales $6.2b, adjusted EPS $10.35-$10.85, FCF $600m, EBITDA margin 22.1% (21.3% ex-refunds).